Family Planning

In light of the new final rule regarding use of Title X federal funds for family planning clinics, Alina Salganicoff, Vice President and Director of Women’s Health Policy at KFF, answers three questions about their impact on women and the clinics that treat them.

The Trump Administration has taken numerous steps to significantly alter the Title X program, the federal grant program that supports family planning services to low-income women. This brief provides an overview of the Title X program, discusses the new 2018 funding announcement and related litigation, and reviews the Trump Administration’s proposed regulations and the implications of these changes.

This map presents the share of Title X clinics that are Planned Parenthood clinics and/or provide abortions (as of 05/2019) and would no longer qualify for funding unless they separate from Planned Parenthood Federation of America or physically separate their abortion services from their family planning care.

Two federal courts have now issued nationwide preliminary injunctions against the new HHS Title X regulations for family planning clinics receiving federal funding. This Chart of the Week breaks down the status of all eight legal challenges nationwide.

With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill…

A new KFF brief examines the return of grantees and clinic sites to the Title X network under the Biden Administration, which reversed Trump Administration regulations that prohibited Title X sites from providing abortion referrals and having co-located abortion services. For more than 50 years, the federal Title X program…

Based on the findings of a nonprobability sample of 6,000 survey respondents from four telecontraception companies, this brief presents a snapshot of telecontraception users and their reasons for using these platforms.

This issue brief examines what has happened to the Title X network under the Biden Administration regulations, including the number of clinics that have returned to the network, new funding, and how state policies that prohibit pregnancy options counseling that includes abortion and referrals may impact grantees’ participation in the Title X program.